Ex-Adviser Cops To Insider Trading Tied To $11B Pharma Deal
A former Florida financial adviser on Monday copped to insider trading charges tied to Gilead Sciences Inc.'s $11 billion acquisition of a New Jersey-based biotechnology company, admitting to a scheme that...To view the full article, register now.
Already a subscriber? Click here to view full article